Emma Walmsley to succeed Andrew Witty as new CEO of GSK

Read the full press release

On Tuesday 20 September 2016, GSK announced that Emma Walmsley, currently Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division, had been appointed GSK CEO Designate and will succeed Andrew Witty as GSK CEO, when he retires on 31 March 2017. Emma will join the GSK Board of Directors from 1 January 2017.